Open AccessInnovative Medicines & Oncology Practice during Covid at MENA Regions Policy analysis
Author(s) -
Abdalla Abotaleb
Publication year - 2020
Language(s) - English
DOI - 10.47363/jonrr/2020(1)109
Subject(s) - covid-19 , pandemic , adaptation (eye) , medicine , value (mathematics) , quality (philosophy) , intensive care medicine , business , oncology , psychology , computer science , virology , philosophy , epistemology , disease , neuroscience , machine learning , outbreak , infectious disease (medical specialty)
Oncology practice during COVID -19 pandemic faced many challenges one of the major challenges is adaptation of treatment protocols for achieving following objectives. Managing system capacity, Enhancement of patient’s outcomes (quality of life – economic value – clinical effectiveness). And utilizing the resources during this hard times. Previous objectives raised many questions about nature of treatment protocols should be implemented during COVID -19. Pandemic and how innovative medicines can achieve the previous objectives.